Skip to content
Clinical Trials – home
Jcr Pharmaceuticals Co. Ltd.
Sponsor

Jcr Pharmaceuticals Co. Ltd.

3-19 Kasugacho, 659-0021

About the sponsor

JCR Pharmaceuticals Co. Ltd. focuses on clinical research in Hunter syndrome, with particular attention to mucopolysaccharidosis type II and its impact on both central nervous system and somatic symptoms.

  • Central nervous system involvement
  • Somatic disease manifestations
  • Long-term symptom control

The sponsor’s trial activity in this area also includes assessment of safety and pharmacokinetics in patients with MPS II.

About Specializations

Jcr Pharmaceuticals Co. Ltd. runs clinical trials in conditions such as Mucopolysaccharidosis II, Mucopolysaccharidosis III, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Long-term Safety and Efficacy Study of JR-141 (Pabinafusp Alfa) for Male Patients with Hunter Syndrome (Mucopolysaccharidosis II)

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pabinafusp Alfa
  • Sponsor:Jcr Pharmaceuticals Co. Ltd.

Study on the Effects and Safety of JR-141 and Idursulfase for Patients with Hunter Syndrome

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Idursulfase
  • Sponsor:Jcr Pharmaceuticals Co. Ltd.

Study of Weekly Infusions of JR-441 for Patients with Mucopolysaccharidosis Type IIIA

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:N-Sulfoglucosamine Sulfohydrolase Fused To A Humanised Monoclonal Antibody Targeting Human Transferrin Receptor
  • Sponsor:Jcr Pharmaceuticals Co. Ltd.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.